An ongoing series led by Dr. Mrinal Gounder of MSK and Dr. Sewanti Limaye of Sir HN Reliance Foundation Hospital in Mumbai
Interpreting results from next-generation genomic sequencing of cancer, and identifying the right drug for the right patient, is a challenge for many cancer specialists today. Join leading global experts for a new educational series from MSK, where we’ll take a deep dive into each of the major cancer signaling pathways and discuss the nuances of precision therapies—with the aim of enhancing our collective understanding. In this quarterly series, we will discuss MEK and subsequently focus on EGFR, HER2, BRCA and HRD, RET/ALK, FGFR, and emerging pathways.
Wednesday, 20 September, 2023
6:00-7:45 p.m. IST | 8:30-10:15 a.m. US ET
Virtual event via Zoom